• Drug: Ofev (nintedanib)
  • Manufacturer: Boehringer Ingelheim

  • Route of Administration: Oral

  • Site of Care: Outpatient
  • Approved Indication:

    • treatment of idiopathic pulmonary fibrosis in adults
    • treatment of chronic fibrosis interstitial lung diseases with a progressive phenotype in adults
    • slowing the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease in adults
  • Disease: idiopathic pulmonary fibrosis (IPF), interstitial lung disease (ILD)

  • Therapeutic Area: Pulmonary

  • Enrollment Form Link: Prescription Form

  • Phone Number: 855-297-5906 (BI Cares)

  • Fax Number: N/A

  • Product Website: ofev.com